Frontlight ResearchEarly access
Gaucher disease trials in Türkiye
2 of 3 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in TürkiyeStudy to Evaluate the Efficacy and Safety of Nizubaglustat (AZ-3102) in Patients With Gaucher Disease Type 3 (GD3)
- Where
- Bornova, Yenimahalle
- Age
- 4 years to 30 years
- People
- 20 worldwide
- Run by
- Azafaros B.V.
See details and how to joinNCT07715084 - Phase 3Taking peopleA Gaucher Disease Gene Therapy Trial With FLT201
- Where
- Ankara
- Age
- 18 years and over
- People
- 45 worldwide
- Run by
- Spur Therapeutics
See details and how to joinNCT07223944 · EU 2025-520765-50-00